首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1422168

馬醫療保健市場 - 成長、未來前景、競爭分析，2023-2031 年

Equine Healthcare Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日期: 2024年01月23日 | 出版商:

Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

在預防性醫療措施、診斷和治療的進步以及對馬術運動和娛樂的日益關注等關鍵驅動因素的推動下，馬醫療保健市場在2024 年至2032 年的預測期內預計將以6.1% 的複合年增長率增長。。然而，成本和訪問挑戰是限制因素。市場區隔強調特定產品類別和適應症的主導地位，而地理趨勢則強調市場動態的區域差異。競爭格局凸顯了領導企業在這個充滿活力的市場中駕馭並利用新機會的策略努力。隨著產業的發展，解決可及性問題並促進創新對於馬醫療保健市場的持續成功至關重要。

越來越重視預防保健

由於人們越來越重視馬匹的預防性保健，馬匹保健市場正經歷顯著成長。馬主和飼養員越來越意識到疫苗和藥物飼料添加劑對於預防疾病和維持馬匹整體健康的重要性。馬界預防性保健的採用顯著增加就證明了這一趨勢。

診斷和治療的進展

馬診斷和藥物的進步對市場成長做出了重大貢獻。針對肌肉骨骼疾病、內科以及馬皰疹病毒和馬流感等病毒感染的先進診斷工具和有效藥物的開發提高了我們診斷和治療各種馬健康狀況的能力。馬獸醫實踐中越來越多地使用先進的診斷方法和藥物就證明了這一趨勢。

對馬術運動和休閒的關注日益增加

馬術運動和娛樂活動的日益普及增加了對針對性能馬的獨特需求量身定制的保健產品和服務的需求。這包括肌肉骨骼疾病和寄生蟲控制的專門治療，以及採用軟體和服務進行全面的醫療保健管理。馬匹越來越多地參與各種市場競爭和休閒活動也是影響市場動態的主要因素。

市場限制因素

儘管趨勢積極，但馬保健市場仍面臨與成本和可及性相關的重大限制因素。先進診斷、藥物和專業醫療保健服務的高昂成本給馬主帶來了挑戰，特別是在馬匹醫療保健資源有限的地區。這種限制阻礙了馬界某些領域採用先進的醫療保健解決方案。

按產品分析市場：藥品主導市場

馬保健市場分為疫苗、藥品、藥物飼料添加劑、診斷、軟體和服務等。由於對各種馬健康狀況的有效治療的需求的推動，藥品在 2023 年的收入最高。然而，軟體和服務業在預測期內（2024-2032）的複合年增長率最高。這是因為馬的醫療保健管理系統已經變得流行並且是馬的整體福利不可或缺的一部分。

按適應症細分市場：肌肉骨骼疾病和寄生蟲控制主導市場

依適應症細分包括肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦脊髓炎、馬流感、西尼羅河病毒、破傷風等。2023 年，肌肉骨骼疾病和寄生蟲控制收入最高，反映出馬匹健康問題的普遍性。然而，預測期內複合年增長率最高的領域是馬皰疹病毒和馬流感，這顯示馬界的健康重點正在改變。

北美仍處於世界領先地位

馬保健市場呈現不同的區域趨勢，收入貢獻和複合年增長率因區域而異。由於其完善的馬術產業和對馬匹保健的高度認識，北美將成為 2023 年最賺錢的地區。然而，預測期內複合年增長率最高的地區預計將是亞太地區。這反映出亞太地區對馬術運動和休閒的興趣日益濃厚，以及對馬匹健康日益關注。

預測期內市場競爭將加劇

馬保健品市場的特徵是競爭激烈，主要參與者包括 Zoetis Inc.、Boehringer Ingelheim、Merck &Co.、Ceva、Sound、Hallmarq Veterinary Imaging、Esaote SPA、Vetoquinol SA、IDEXX Laboratories, Inc. 和 Dechra Pharmaceuticals PLC。這些公司採用產品創新、聯盟和收購等策略來加強其市場地位。2023 年，這些參與者的市場總收入為[說明實際收入數字]，預計在 2024 年至 2032 年的預測期內將增加。

介紹
2022-2032 年全球馬保健品市場價值
市場動態
- 市場驅動力
- 市場制約因素
- 主要問題
- 主要機會
促進因素和抑制因素的影響分析
蹺蹺板分析
波特的五力模型
- 供應商實力
- 購買力
- 替代品的威脅
- 新進入者的威脅
- 競爭對手之間的競爭
PESTEL 分析
- 政局
- 金融情況
- 技術景觀
- 法律狀況
- 社會局勢

第五章馬保健市場：依產品 2022-2032

市場概況
成長/利潤分析：2023 年與 2032 年
2022-2032年數量和價格分析
市場細分
- 疫苗接種
- 藥品
  - 寄生劑
  - 抗感染藥
  - 消炎鎮痛藥
  - 其他藥品
- 藥用飼料添加劑
- 診斷
- 軟件和服務
- 其他

第六章馬保健市場：依適應症分類 2022-2032

市場概況
成長/利潤分析：2023 年與 2032 年
2022-2032年數量和價格分析
市場細分
- 肌肉骨骼疾病
- 寄生蟲控制
- 內科
- 馬皰疹病毒
- 馬腦脊髓炎
- 馬流感
- 西尼羅河病毒
- 破傷風
- 其他

第 7 章馬醫療保健市場：依活動劃分 2022-2032

市場概況
成長/利潤分析：2023 年與 2032 年
2022-2032年數量和價格分析
市場細分
- 運動/競賽
- 娛樂
- 其他

第 8 章馬醫療保健市場：依分銷管道劃分 2022-2032

市場概況
成長/利潤分析：2023 年與 2032 年
2022-2032年數量和價格分析
市場細分
- 獸醫醫院和診所
- 電子商務
- 其他

第9章北美馬醫療保健市場2022-2032

市場概況
馬醫療保健市場：依產品分類 2022-2032
馬醫療保健市場：依適應症分類 2022-2032
馬醫療保健市場：依活動分類 2022-2032
馬醫療保健市場：按分銷管道劃分 2022-2032
馬醫療保健市場：按地區劃分 2022-2032
- 北美
  - 美國
  - 加拿大
  - 其他北美

第 10 章英國和歐盟馬醫療保健市場 2022-2032

市場概況
馬醫療保健市場：依產品分類 2022-2032
馬醫療保健市場：依適應症分類 2022-2032
馬醫療保健市場：依活動分類 2022-2032
馬醫療保健市場：按分銷管道劃分 2022-2032
馬醫療保健市場：按地區劃分 2022-2032
- 英國和歐盟
  - 英國
  - 德國
  - 西班牙
  - 義大利
  - 法國
  - 歐洲其他地區

第十一章 2022-2032 年亞太地區馬醫療保健市場

市場概況
馬醫療保健市場：依產品分類 2022-2032
馬醫療保健市場：依適應症分類 2022-2032
馬醫療保健市場：依活動分類 2022-2032
馬醫療保健市場：按分銷管道劃分 2022-2032
馬醫療保健市場：按地區劃分 2022-2032
- 亞太地區
  - 中國
  - 日本
  - 印度
  - 澳大利亞
  - 韓國
  - 亞太其他地區

第十二章拉丁美洲馬醫療保健市場 2022-2032

市場概況
馬醫療保健市場：依產品分類 2022-2032
馬醫療保健市場：依適應症分類 2022-2032
馬醫療保健市場：依活動分類 2022-2032
馬醫療保健市場：按分銷管道劃分 2022-2032
馬醫療保健市場：按地區劃分 2022-2032
- 拉丁美洲
  - 巴西
  - 墨西哥
  - 其他拉丁美洲地區

第十三章 2022-2032 年中東和非洲馬醫療保健市場

市場概況
馬醫療保健市場：依產品分類 2022-2032
馬醫療保健市場：依適應症分類 2022-2032
馬醫療保健市場：依活動分類 2022-2032
馬醫療保健市場：按分銷管道劃分 2022-2032
馬醫療保健市場：按地區劃分 2022-2032
- 中東/非洲
  - GCC
  - 非洲
  - 其他中東/非洲地區

第十四章公司簡介

Zoetis Inc.
Boehringer Ingelheim
Merck & Co.
Ceva
Sound
Hallmarq Veterinary Imaging
Esaote SPA
Vetoquinol S.A.
IDEXX Laboratories Inc.
Dechra Pharmaceuticals PLC
其他主要公司

簡介目錄圖表

Product Code: 138524-01-24

The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics. The competitive landscape emphasizes the strategic efforts of key players to navigate this dynamic market and capitalize on emerging opportunities. As the industry evolves, addressing accessibility issues and fostering innovation will be crucial for sustained success in the equine healthcare market.

Increasing Emphasis on Preventive Healthcare

The equine healthcare market is experiencing a notable boost due to the rising emphasis on preventive healthcare measures for horses. Horse owners and caretakers are increasingly recognizing the importance of vaccines and medicinal feed additives to prevent diseases and maintain the overall health of equines. This trend is evidenced by a substantial increase in the adoption of preventive healthcare practices in the equine community.

Advancements in Diagnostics and Treatment

Advancements in equine diagnostics and pharmaceuticals have significantly contributed to the market's growth. The development of sophisticated diagnostic tools and effective pharmaceuticals for musculoskeletal disorders, internal medicine, and viral infections like Equine Herpes Virus and Equine Influenza has enhanced the ability to diagnose and treat various health conditions in horses. This trend is substantiated by the increasing use of advanced diagnostics and pharmaceuticals in equine veterinary practices.

Rising Focus on Equine Sports and Recreation

The growing popularity of equine sports and recreational activities is driving the demand for healthcare products and services tailored to the unique needs of performance horses. This includes specialized treatments for musculoskeletal disorders and parasite control, as well as the adoption of software and services for comprehensive healthcare management. The increasing engagement of horses in various competitive and leisure activities is a key driver influencing market dynamics.

Market Restraint

Despite the positive trends, the equine healthcare market faces a notable restraint related to cost and accessibility. The high cost of advanced diagnostics, pharmaceuticals, and specialized healthcare services poses a challenge for horse owners, especially in regions where accessibility to equine healthcare resources is limited. This constraint hinders the widespread adoption of advanced healthcare solutions in certain segments of the equine community.

Market Analysis by Product: Pharmaceuticals Dominate the Market

The equine healthcare market is segmented into vaccines, pharmaceuticals, medicinal feed additives, diagnostics, software & services, and others. In 2023, the highest revenue was generated by pharmaceuticals, driven by the demand for effective treatments for various equine health conditions. However, the highest CAGR during the forecast period (2024-2032) is expected in the software & services segment, as equine healthcare management systems gain traction and become integral to overall equine welfare.

Market Segmentation by Indication: Musculoskeletal Disorders and Parasite Control Dominate the Market

The indication-based segmentation includes musculoskeletal disorders, parasite control, internal medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, and others. In 2023, musculoskeletal disorders and parasite control recorded the highest revenue, reflecting the prevalent health concerns among horses. However, the highest CAGR during the forecast period is expected in the Equine Herpes Virus and Equine Influenza segments, indicating a shifting landscape of health priorities in the equine community.

North America Remains the Global Leader

The equine healthcare market exhibits diverse geographic trends, with varying revenue contributions and CAGR across regions. North America emerged as the region with the highest revenue in 2023, driven by a well-established equine industry and a high level of awareness regarding equine healthcare. However, the region with the highest CAGR during the forecast period is anticipated to be Asia-Pacific, reflecting a growing interest in equine sports and recreation and an increasing focus on equine health in this region.

Market Competition to Intensify during the Forecast Period

The equine healthcare market features intense competition among key players, including Zoetis Inc., Boehringer Ingelheim, Merck & Co., Ceva, Sound, Hallmarq Veterinary Imaging, Esaote SPA, Vetoquinol S.A., IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, and others. These companies employ strategies such as product innovation, collaborations, and acquisitions to strengthen their market position. In 2023, the total market revenues for these players were [provide actual revenue figures], with an expected increase during the forecast period from 2024 to 2032.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEquine Healthcare market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Equine Healthcare market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Vaccines

Pharmaceuticals

Parasiticides

Anti-infectives

Anti-inflammatory & Analgesics

Other Pharmaceuticals

Medicinal Feed Additives

Diagnostics

Software & Services

Others

Indication

Musculoskeletal Disorders

Parasite Control

Internal Medicine

Equine Herpes Virus

Equine Encephalomyelitis

Equine Influenza

West Nile Virus

Tetanus

Others

Activity

Sports/Racing

Recreation

Others

Distribution Channel

Veterinary Hospitals & Clinics

E-commerce

Others

Region Segment (2021-2031; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Equine Healthcare market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Equine Healthcare market?

Which is the largest regional market for Equine Healthcare market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Equine Healthcare market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Equine Healthcare market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Equine Healthcare Market
2.2. Global Equine Healthcare Market, By Product, 2023 (US$ Million)
2.3. Global Equine Healthcare Market, By Indication, 2023 (US$ Million)
2.4. Global Equine Healthcare Market, By Activity, 2023 (US$ Million)
2.5. Global Equine Healthcare Market, By Distribution Channel, 2023 (US$ Million)
2.6. Global Equine Healthcare Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Equine Healthcare Market: Competitive Analysis

3.1. Market Positioning of Key Equine Healthcare Market Vendors
3.2. Strategies Adopted by Equine Healthcare Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Equine Healthcare Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Equine Healthcare Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape

5. Equine Healthcare Market: By Product, 2022-2032, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Volume and Pricing Analysis, 2022-2032
5.4. Market Segmentation
- 5.4.1. Vaccines
- 5.4.2. Pharmaceuticals
  - 5.4.2.1. Parasiticides
  - 5.4.2.2. Anti-infectives
  - 5.4.2.3. Anti-inflammatory & Analgesics
  - 5.4.2.4. Other Pharmaceuticals
- 5.4.3. Medicinal Feed Additives
- 5.4.4. Diagnostics
- 5.4.5. Software & Services
- 5.4.6. Others

6. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Volume and Pricing Analysis, 2022-2032
6.4. Market Segmentation
- 6.4.1. Musculoskeletal Disorders
- 6.4.2. Parasite Control
- 6.4.3. Internal Medicine
- 6.4.4. Equine Herpes Virus
- 6.4.5. Equine Encephalomyelitis
- 6.4.6. Equine Influenza
- 6.4.7. West Nile Virus
- 6.4.8. Tetanus
- 6.4.9. Others

7. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Volume and Pricing Analysis, 2022-2032
7.4. Market Segmentation
- 7.4.1. Sports/Racing
- 7.4.2. Recreation
- 7.4.3. Others

8. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Volume and Pricing Analysis, 2022-2032
8.4. Market Segmentation
- 8.4.1. Veterinary Hospitals & Clinics
- 8.4.2. E-commerce
- 8.4.3. Others

9. North America Equine Healthcare Market, 2022-2032, USD (Million)

9.1. Market Overview
9.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
9.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
9.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
9.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
9.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
- 9.6.1.North America
  - 9.6.1.1. U.S.
    - 9.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 9.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 9.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 9.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.6.1.2. Canada
    - 9.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 9.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 9.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 9.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.6.1.3. Rest of North America
    - 9.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 9.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 9.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 9.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

10. UK and European Union Equine Healthcare Market, 2022-2032, USD (Million)

10.1. Market Overview
10.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
10.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
10.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
10.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
- 10.6.1.UK and European Union
  - 10.6.1.1. UK
    - 10.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 10.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 10.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.6.1.2. Germany
    - 10.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 10.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 10.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.6.1.3. Spain
    - 10.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 10.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 10.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.6.1.4. Italy
    - 10.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 10.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 10.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.6.1.5. France
    - 10.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 10.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 10.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.6.1.6. Rest of Europe
    - 10.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 10.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 10.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

11. Asia Pacific Equine Healthcare Market, 2022-2032, USD (Million)

11.1. Market Overview
11.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
11.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
11.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
11.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
- 11.6.1.Asia Pacific
  - 11.6.1.1. China
    - 11.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 11.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 11.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.6.1.2. Japan
    - 11.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 11.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 11.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.6.1.3. India
    - 11.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 11.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 11.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.6.1.4. Australia
    - 11.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 11.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 11.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.6.1.5. South Korea
    - 11.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 11.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 11.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.6.1.6. Rest of Asia Pacific
    - 11.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 11.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 11.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

12. Latin America Equine Healthcare Market, 2022-2032, USD (Million)

12.1. Market Overview
12.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
12.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
12.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
12.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
12.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
- 12.6.1.Latin America
  - 12.6.1.1. Brazil
    - 12.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 12.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 12.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 12.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 12.6.1.2. Mexico
    - 12.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 12.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 12.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 12.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 12.6.1.3. Rest of Latin America
    - 12.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 12.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 12.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 12.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

13. Middle East and Africa Equine Healthcare Market, 2022-2032, USD (Million)

13.1. Market Overview
13.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
13.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
13.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
13.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
13.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
- 13.6.1.Middle East and Africa
  - 13.6.1.1. GCC
    - 13.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 13.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 13.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 13.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 13.6.1.2. Africa
    - 13.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 13.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 13.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 13.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  - 13.6.1.3. Rest of Middle East and Africa
    - 13.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
    - 13.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
    - 13.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
    - 13.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

14. Company Profile

14.1. Zoetis Inc.
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
14.2. Boehringer Ingelheim
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
14.3. Merck & Co.
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
14.4. Ceva
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
14.5. Sound
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
14.6. Hallmarq Veterinary Imaging
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
14.7. Esaote SPA
- 14.7.1. Company Overview
- 14.7.2. Financial Performance
- 14.7.3. Product Portfolio
- 14.7.4. Strategic Initiatives
14.8. Vetoquinol S.A.
- 14.8.1. Company Overview
- 14.8.2. Financial Performance
- 14.8.3. Product Portfolio
- 14.8.4. Strategic Initiatives
14.9. IDEXX Laboratories, Inc.
- 14.9.1. Company Overview
- 14.9.2. Financial Performance
- 14.9.3. Product Portfolio
- 14.9.4. Strategic Initiatives
14.10. Dechra Pharmaceuticals PLC
- 14.10.1. Company Overview
- 14.10.2. Financial Performance
- 14.10.3. Product Portfolio
- 14.10.4. Strategic Initiatives
14.11. Other Notable Players
- 14.11.1. Company Overview
- 14.11.2. Financial Performance
- 14.11.3. Product Portfolio
- 14.11.4. Strategic Initiatives

簡介目錄圖表

List of Tables

TABLE 1 Global Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 2 Global Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 3 Global Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 4 Global Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 5 Global Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 6 North America Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 7 North America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 8 North America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 9 North America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 10 North America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 11 U.S. Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 12 U.S. Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 13 U.S. Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 14 U.S. Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 15 U.S. Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 16 Canada Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 17 Canada Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 18 Canada Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 19 Canada Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 20 Canada Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 21 Rest of North America Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 22 Rest of North America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 23 Rest of North America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 24 Rest of North America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 25 Rest of North America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 26 UK and European Union Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 27 UK and European Union Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 28 UK and European Union Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 29 UK and European Union Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 30 UK and European Union Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 31 UK Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 32 UK Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 33 UK Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 34 UK Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 35 UK Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 36 Germany Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 37 Germany Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 38 Germany Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 39 Germany Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 40 Germany Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 41 Spain Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 42 Spain Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 43 Spain Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 44 Spain Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 45 Spain Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 46 Italy Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 47 Italy Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 48 Italy Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 49 Italy Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 50 Italy Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 51 France Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 52 France Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 53 France Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 54 France Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 55 France Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 56 Rest of Europe Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 57 Rest of Europe Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 58 Rest of Europe Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 59 Rest of Europe Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 60 Rest of Europe Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 61 Asia Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 62 Asia Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 63 Asia Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 64 Asia Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 65 Asia Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 66 China Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 67 China Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 68 China Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 69 China Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 70 China Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 71 Japan Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 72 Japan Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 73 Japan Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 74 Japan Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 75 Japan Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 76 India Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 77 India Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 78 India Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 79 India Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 80 India Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 81 Australia Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 82 Australia Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 83 Australia Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 84 Australia Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 85 Australia Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 86 South Korea Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 87 South Korea Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 88 South Korea Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 89 South Korea Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 90 South Korea Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 91 Latin America Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 92 Latin America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 93 Latin America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 94 Latin America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 95 Latin America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 96 Brazil Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 97 Brazil Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 98 Brazil Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 99 Brazil Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 100 Brazil Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 101 Mexico Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 102 Mexico Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 103 Mexico Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 104 Mexico Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 105 Mexico Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 106 Rest of Latin America Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 107 Rest of Latin America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 108 Rest of Latin America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 109 Rest of Latin America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 110 Rest of Latin America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 111 Middle East and Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 112 Middle East and Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 113 Middle East and Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 114 Middle East and Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 115 Middle East and Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 116 GCC Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 117 GCC Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 118 GCC Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 119 GCC Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 120 GCC Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 121 Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 122 Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 123 Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 124 Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 125 Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 126 Rest of Middle East and Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
TABLE 127 Rest of Middle East and Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 128 Rest of Middle East and Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

TABLE 129 Rest of Middle East and Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
TABLE 130 Rest of Middle East and Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)

List of Figures

FIG. 1 Global Equine Healthcare Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Equine Healthcare Market: Quality Assurance
FIG. 5 Global Equine Healthcare Market, By Product, 2023
FIG. 6 Global Equine Healthcare Market, By Indication, 2023
FIG. 7 Global Equine Healthcare Market, By Activity, 2023
FIG. 8 Global Equine Healthcare Market, By Distribution Channel, 2023
FIG. 9 Global Equine Healthcare Market, By Geography, 2023
FIG. 10 Market Geographical Opportunity Matrix - Global Equine Healthcare Market, 2023

FIG. 11Market Positioning of Key Equine Healthcare Market Players, 2023

FIG. 12Global Equine Healthcare Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

FIG. 13 Global Equine Healthcare Market, By Product, 2023 Vs 2032, %
FIG. 14 Global Equine Healthcare Market, By Indication, 2023 Vs 2032, %
FIG. 15 Global Equine Healthcare Market, By Activity, 2023 Vs 2032, %
FIG. 16 Global Equine Healthcare Market, By Distribution Channel, 2023 Vs 2032, %
FIG. 17 U.S. Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 18 Canada Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 19 Rest of North America Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 20 UK Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 21 Germany Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 22 Spain Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 23 Italy Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 24 France Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 25 Rest of Europe Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 26 China Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 27 Japan Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 28 India Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 29 Australia Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 30 South Korea Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 31 Rest of Asia Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 32 Brazil Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 33 Mexico Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 34 Rest of Latin America Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 35 GCC Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 36 Africa Equine Healthcare Market (US$ Million), 2022 - 2032
FIG. 37 Rest of Middle East and Africa Equine Healthcare Market (US$ Million), 2022 - 2032